Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease by Pawan Kumar Gupta, Santanu Dutta, Sanjay Kala, Muralikrishna Nekkanti, Sanjay C. Desai, Subhendu S. Mahapatra, Anita Dhar, Radhakrishnan Raju, Rajkumar M., Arunanshu Behera, Shivashankar P., N.S. Raviraja, Pachaiyappan Viswanathan, Mithun Chandrashekar, Charan Thej, Prasanth K.V., Jijy Abraham, Hema Boggarapu, K. Udaykumar

Get full text